Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous labetalol versus intravenous hydralazine for severe preeclampsia in Calabar
PACTR202605730239287Not yet recruiting
- Sponsor
- Dr. Abeng Mbina Adomi
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in preeclampsia comparing Intravenous labetalol with Intravenous hydralazine (2 arms). Primary endpoints: Time to blood pressure control and Number of doses required. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
labetalolhydralazine
03
Conditions
preeclampsia
Beyond the preview
Go deeper on PACTR202605730239287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202605730239287.